Biomea Fusion, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
BMEA Nasdaq 2836 biomeafusion.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biomea Fusion, Inc.

While institutions invested in Biomea Fusion, Inc. (NASDAQ:BMEA) benefited from last week's 15% gain, retail investors stood to gain the most - Jul 15th, 2025 8:51 am
Biomea Fusion announces presentation of icovamenib preclinical, clinical data - Jun 24th, 2025 11:07 am
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA) - Jun 23rd, 2025 5:00 am
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates - Jun 18th, 2025 5:00 am
Biomea Fusion Announces Pricing of Public Offering of Securities - Jun 17th, 2025 9:15 pm
Biomea Fusion Announces Proposed Public Offering of Securities - Jun 17th, 2025 2:33 pm
Biomea Fusion Presents Updated Preliminary Clinical Data for Covalent FLT3 Inhibitor BMF-500 in Relapsed or Refractory Acute Leukemia at EHA 2025 - Jun 13th, 2025 4:45 am
3 Promising Penny Stocks With Market Caps Over $90M - Jun 4th, 2025 6:05 am
Biomea Fusion (BMEA) Upgraded to Buy: Here's What You Should Know - Jun 3rd, 2025 10:00 am
Biomea Fusion’s BMF-500 Selected for Poster Presentation at EHA 2025 Highlighting Phase I Data in Relapsed/Refractory Acute Leukemia - May 14th, 2025 2:05 pm
Biomea Fusion Reports First Quarter 2025 Financial Results and Corporate Highlights - May 5th, 2025 2:05 pm
After Plunging -27.9% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Apr 2nd, 2025 7:35 am
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Apr 1st, 2025 2:01 pm
After Plunging -19.32% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Apr 1st, 2025 7:35 am
Biomea Fusion Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Highlights - Mar 31st, 2025 2:10 pm
After Plunging -20.42% in 4 Weeks, Here's Why the Trend Might Reverse for Biomea Fusion (BMEA) - Mar 31st, 2025 7:35 am
Biomea Fusion Announces Leadership Transition - Mar 25th, 2025 5:00 pm
Freightos And 2 Other Penny Stocks Worth Watching - Mar 24th, 2025 11:05 am
Icovamenib Treatment in Patients with Severe Insulin-Deficient Diabetes Led to a Significant Improvement in Pancreatic Beta-cell Function with a 53% Mean Increase in C-peptide Levels 3 Months After Last Dose - Mar 24th, 2025 6:30 am
Biomea Fusion Insiders Recover Some Losses, Which Stand At US$91k - Mar 22nd, 2025 8:30 am